Efficacy and safety of ibuprofen injection for postoperative analgesia in patients undergoing general anesthesia: prospective, multicenter, randomized, double-blind, negative-controlled, clinical trial
曾媛,王东信,岳云,马虹,吴秀英,张丽,薛张纲,王明山,欧阳文,刘功俭,俞光荣,于浩
DOI: https://doi.org/10.3760/cma.j.cn131073.20200612.00915
2020-01-01
Abstract:Objective:To evaluate the efficacy and safety of ibuprofen injection for postoperative analgesia in the patients undergoing general anesthesia.Methods:This prospective, multicenter, randomized, double-blind, negative-controlled trial was conducted in 360 patients of both sexes, aged 18-75 yr, of American Society of Anesthesiologists physical statusⅠ-Ⅲ, scheduled to undergo elective abdominal or orthopedic surgery under general anesthesia.All the patients were assigned to one of 3 groups (
n=120 each) using a random number tale method: control group (group C), ibuprofen injection 400 mg group (group B1), and ibuprofen injection 800 mg group (group B2). At 30 min before the end of surgery, ibuprofen injection 400 and 800 mg (in 0.9% sodium chloride injection 200 ml) were intravenously infused over 30 min in B1 and B2 groups, respectively, and 0.9% sodium chloride injection 200 ml was intravenously infused over 30 min in group C, and then infusion was performed every 6 h until 48 h after operation.The analgesic pump was connected after operation to perform patient-controlled intravenous analgesia (PCIA), and the PCIA solution contained 0.5 mg/ml morphine in 0.9% sodium chloride injection.The PCA pump was set up with a 2 ml bolus dose, a 5 min lockout interval and background infusion at a rate of 0.25 ml/h.The analgesia lasted for 48 h after operation, and the visual analog scale score was maintained ≤ 4 points.Effectiveness index: the consumption of morphine within 24 and 48 h after operation, the total pressing times of PCA and effective pressing times of PCA, the requirement for rescue analgesia within 48 h after operation and patient′s overall evaluation of the analgesia effect at 48 h after operation were recorded.Safety index: the occurrence of adverse reactions (nausea, vomiting, pruritus, injection pain, dizziness, etc.) within 48 h after medication were recorded; the laboratory examinations including blood biochemical examination, blood routine examination, blood coagulation function examination and urine routine examination were performed at 48 h after medication, and abnormal conditions were recorded.
Results:Compared with group C, the postoperative consumption of morphine, total pressing times of PCA, effective pressing times of PCA, and requirement for rescue analgesia were significantly decreased, and the rates of excellent and excellent+ good evaluation of analgesic effects by patients were increased in B1 and B2 groups (
P<0.05). There was no significant difference in the parameters mentioned above between B1 group and B2 group (
P>0.05). There was no significant difference in the incidence of nausea, vomiting, pruritus, injection pain and dizziness and rates of abnormalities in laboratory examinations among the three groups (
P>0.05).
Conclusion:Ibuprofen injection can be safely and effectively used for postoperative analgesia in the patients undergoing general anesthesia.